Diabetes News and Research

Latest Diabetes News and Research

Stroke warning for bipolar patients

Patients with bipolar disorder are at an increased risk for having a stroke and for dying soon after their stroke, a study shows.

25 Sep 2013

UCSF inaugurates new endowment of PhD education programs in basic sciences

Sequoia Capital Chairman Sir Michael Moritz, KBE, and his wife, Harriet Heyman, in collaboration with UC San Francisco, have kicked off a new endowment with a $60 million contribution to ensure the future of PhD education programs in the basic sciences.

25 Sep 2013

Study on tempol impacted gut bacteria may lead to new treatments for obesity

A drug that appears to target specific intestinal bacteria in the guts of mice may create a chain reaction that could eventually lead to new treatments for obesity and diabetes in humans, according to a team of researchers.

25 Sep 2013

Engineered nanomaterials inhalation negatively impacts gestational development in animal models

After a decade of rapidly growing industrial use, unimaginably tiny particles surround us everywhere, every day, in everything we do. Used in the manufacturing of cosmetics, clothing, paints, food, drug delivery systems and many other familiar products we all use daily, little is known about the effects these materials have on health.

25 Sep 2013

Targeted radiation therapy may offer safe treatment option for elderly pancreatic cancer patients

A highly targeted cancer radiation therapy may offer a safe and effective treatment option for elderly pancreatic cancer patients unable to undergo surgery or combined chemotherapy and radiation therapy, according to researchers at Henry Ford Hospital in Detroit.

25 Sep 2013

Use of insulin pump with sensor reduces rate of severe hypoglycemia

Use of an insulin pump with a sensor that suspends insulin delivery when blood glucose falls below a set threshold reduced the rate of severe and moderate hypoglycemia among patients with type 1 diabetes and impaired awareness of hypoglycemia, according to a study in the September 25 issue of JAMA.

25 Sep 2013

$Researchers show link between FTO gene and hip fracture in women$

Researchers show link between FTO gene and hip fracture in women

Australian researchers have demonstrated a strong association between the FTO (fat and obesity) gene and hip fracture in women. While the gene is already well known to affect diabetes and obesity, this is the first study to show that its high-risk variant can increase the risk of hip fracture by as much as 82%.

25 Sep 2013

Study shows how deadly Candida albicans might be rendered harmless

Candida albicans is a double agent: In most of us, it lives peacefully, but for people whose immune systems are compromised by HIV or other severe illnesses, it is frequently deadly. Now a new study from Johns Hopkins and Harvard Medical School shows how targeting a specific fungal component might turn the fungus from a lion back into a kitten.

25 Sep 2013

Rhythm starts RM-493 clinical trials in obesity patients with genetic deficiency

Rhythm announced today the initiation of the first of a series of clinical trials with RM-493, the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of obesity in individuals with a genetic deficiency in the MC4R pathway.

24 Sep 2013

New laser provides better treatment for eye diseases in diabetes patients

A new laser is helping experts at the Truhlsen Eye Institute at the University of Nebraska Medical Center provide better treatment for eye diseases. This advanced laser can prevent blindness for some patients with serious conditions.

24 Sep 2013

Changes in national diets linked to dramatic rise in AD prevalence in Japan and developing countries

In a paper just published electronically in the Journal of Alzheimer's Disease, dramatic increases in Alzheimer's disease in Japan and significant increases in developing countries are linked to changes in national diets.

24 Sep 2013

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Boehringer Ingelheim and Eli Lilly and Company today announced results from two post-hoc, pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the dipeptidyl peptidase-4 inhibitor linagliptin in adults with type 2 diabetes.

24 Sep 2013

Discovery could help develop new treatments for blood diseases

Researchers in Melbourne, Australia, have found that even our immune system is subject to performance enhancement, with our bodies giving immune cells the boost they need to ensure the best team is selected to fight infections.

24 Sep 2013

Adults across the U.S. rate childhood cancer as top priority for research into improving children's health

Adults across the U.S. rate childhood cancer as their top priority for research into improving children's health, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health.

24 Sep 2013

Mayo Clinic expands genomic research by establishing biobank at Arizona campus

Mayo Clinic has again broadened the base of its genomic research efforts by establishing a biobank at its Arizona campus, which will support studies in obesity, metabolism and diabetes, all areas of special concern in the Latino population.

24 Sep 2013

Alefacept drug shows encouraging results in phase 2 trial for type 1 diabetes

A drug formerly used to treat the skin disorder psoriasis has shown encouraging results in a phase 2 trial to assess its effectiveness in treating type 1 diabetes, according to new research published in The Lancet Diabetes & Endocrinology.

24 Sep 2013

Understanding genetic, physiological basis for metabolic diseases related to circadian function

A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum of metabolic diseases related to circadian function.

24 Sep 2013

FDA's final guidance outlines tailored approach to mobile medical apps

Today, the U.S. Food and Drug Administration issued final guidance for developers of mobile medical applications, or apps, which are software programs that run on mobile communication devices and perform the same functions as traditional medical devices. The guidance outlines the FDA's tailored approach to mobile apps.

24 Sep 2013

Addition of walnuts to diet can protect against diabetes and heart disease in at-risk individuals

Medical researchers from the Yale-Griffin Prevention Research Center in Connecticut have found evidence suggestive that adding walnuts to one's diet can protect against diabetes and heart disease in at-risk individuals.

24 Sep 2013

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.

23 Sep 2013

Diabetes News and Research

Latest Diabetes News and Research

Stroke warning for bipolar patients

UCSF inaugurates new endowment of PhD education programs in basic sciences

Study on tempol impacted gut bacteria may lead to new treatments for obesity

Engineered nanomaterials inhalation negatively impacts gestational development in animal models

Targeted radiation therapy may offer safe treatment option for elderly pancreatic cancer patients

Use of insulin pump with sensor reduces rate of severe hypoglycemia

Researchers show link between FTO gene and hip fracture in women

Study shows how deadly Candida albicans might be rendered harmless

Rhythm starts RM-493 clinical trials in obesity patients with genetic deficiency

New laser provides better treatment for eye diseases in diabetes patients

Changes in national diets linked to dramatic rise in AD prevalence in Japan and developing countries

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Discovery could help develop new treatments for blood diseases

Adults across the U.S. rate childhood cancer as top priority for research into improving children's health

Mayo Clinic expands genomic research by establishing biobank at Arizona campus

Alefacept drug shows encouraging results in phase 2 trial for type 1 diabetes

Understanding genetic, physiological basis for metabolic diseases related to circadian function

FDA's final guidance outlines tailored approach to mobile medical apps

Addition of walnuts to diet can protect against diabetes and heart disease in at-risk individuals

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Genomics - Industry Focus eBook (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in